Iboxamycin
Iboxamycin is a potent antibiotic candidate bearing a fused bicyclic amino acid residue. Iboxamycin is orally bioavailable, safe and effective in researching both Gram-positive and Gram-negative bacterial infections in mice[1][2].
Product Specifications
CAS Number
2640000-92-4
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/iboxamycin.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H](NC1)[C@@](OCC2)([H])[C@@]1([H])C[C@@H]2CC(C)C)N[C@@H]([C@@]([C@@H]([C@@H]3O)O)([H])O[C@@H]([C@@H]3O)SC)[C@@H](Cl)C
Molecular Formula
C22H39ClN2O6S
Molecular Weight
495.07
References & Citations
[1]Mason JD, et al. Practical Gram-Scale Synthesis of Iboxamycin, a Potent Antibiotic Candidate. J Am Chem Soc. 2021;143 (29) :11019-11025. |[2]Mitcheltree MJ, et al. A synthetic antibiotic class overcoming bacterial multidrug resistance. Nature. 2021;599 (7885) :507-512.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL319366V 500 µL Each
na Human shRNA Lentiviral Particle (Locus ID 147346)
Sign In for Pricing
View Details 
orb2922536-01 20 µg
Recombinant Human Cutaneous T-cell lymphoma-associated antigen 4 (CTAGE4)
Sign In for Pricing
View Details orb2922536-02 100 µg
Recombinant Human Cutaneous T-cell lymphoma-associated antigen 4 (CTAGE4)
Sign In for Pricing
View Details VAng-Wyb0622-inquire Inquire
Recombinant Salmonella sopB Protein (aa 1-561)
Sign In for Pricing
View Details 